Hi JoAnn,
We had a recent situation with suspected fentanyl diversion and made a recommendation similar to the approach that your hospital takes where the intervention would be made during the
middle or near the end of the shift. The director of the unit was not comfortable with that approach from a patient safety perspective. How do you address patient safety while the suspected diverter works his/her shift?
Thanks,
Meredith
From: MCOH-EH [mailto:mcoh-eh-bounces+weaverm=wvumedicine.org@mylist.net]
On Behalf Of Joann via MCOH-EH Shea [*]
Sent: Wednesday, May 9, 2018 3:38 PM
To: MCOH/EH <mcoh-eh@mylist.net>
Cc: Shea, Joann <jshea@tgh.org>
Subject: Re: [MCOH-EH] Suspected fentanyl use
We developed a healthcare professional panel with our lab that includes fentanyl and do a urine test when we have a suspected diversion. If we suspect fentanyl diversion, we arrange for the intervention in
the middle or near the end of the HCW’s shift, as most will use it sometime during their shift and/or have drug in their possession when we search them and their belongings. We get a positive urine drug screen results for fentanyl in most cases when we
intervene in the middle or end of shift.
We contract with CRL and FedEX all urine specimens out for next day service. We get results within 2-4 days, on average.
JoAnn Shea, ARNP, MS, COHN-S
Director, Employee Health & Wellness “Caring for our Caregivers”
Work: 813-844-7692 Cell: 813-789-3441 FAX; 813-844-8144 Email: jshea@tgh.org
From: MCOH-EH [mailto:mcoh-eh-bounces@mylist.net]On
Behalf Of Yvonne Noel via MCOH-EH
Sent: Tuesday, May 01, 2018 11:29 AM
To: MCOH/EH
Cc: Yvonne Noel
Subject: [MCOH-EH] Suspected fentanyl use
|
CAUTION:This email originated from outside of the organization. Do not click links or open attachments unless you recognize the sender and know the content is safe. |
I would appreciate info on the following questions related to suspected fentanyl use:
·
How would you proceed if an employee was suspected of fentanyl use?
·
Would you test urine, saliva or blood?
·
Can you provide the information on the screening panel used?
·
Where would the specimen be sent for testing?
Thank you,
Yvonne Noel
Yvonne Noel
Interim Manager
Occupational Health and Wellness
O: 214-456-1897
F: 214-456-2665
E:mary.noel@childrens.com
Please consider the environment before printing this e-mail
This e-mail, facsimile, or letter and any files or attachments transmitted with it contains
information that is confidential and privileged. This information is intended only for the use of the
individual(s) and entity(ies) to whom it is addressed. If you are the intended recipient, further
disclosures are prohibited without proper authorization. If you are not the intended recipient, any
disclosure, copying, printing, or use of this information is strictly prohibited and possibly a
violation of federal or state law and regulations. If you have received this information in error,
please notify us via e-mail at privacy@childrens.com. Children's Health System of Texas and its affiliates hereby claim all
applicable privileges related to this information.
This message and any included attachments are from Nebraska Methodist Health System and its affiliates and are intended only for the addressee. The message may contain privileged,
confidential and/or proprietary information intended only for the person(s) named. Unauthorized forwarding, printing, copying, distribution, or use of such information is strictly prohibited and may be unlawful. If you are not the addressee, please promptly
delete this message and notify the sender of the delivery error by e-mail or you may call Nebraska Methodist Health System and its affiliates in Omaha, Nebraska, U.S.A at (402)354-2280.